Sign In
Buy ELV
$388.50
-2.77 (-0.708%)
At Close: Jun 18, 2026
Health Insurance Stock Could Rebound Off Historically Bullish Signal
02:44pm, Thursday, 29'th Jan 2026
Elevance Health Inc (NYSE:ELV) stock yesterday enjoyed its biggest single-day percentage gain since May 2024 after reporting $547 million in profits, but it wasn't enough to erase its worst day since
Elevance Health (NYSE:ELV) Stock Price Up 6.3% on Strong Earnings
01:32am, Thursday, 29'th Jan 2026
Elevance Health, Inc. (NYSE: ELV - Get Free Report)'s stock price rose 6.3% on Wednesday following a stronger than expected earnings report. The stock traded as high as $343.86 and last traded at $343
Market Today: Fed Pause, Big Tech Earnings, Gold Soars
05:35pm, Wednesday, 28'th Jan 2026
Guru Stock PicksMurray Stahl has made the following transactions:Reduce in CVEO by 8.96%Add in SJT by 11.03%Eaton Vance Worldwide Health Sciences Fund has made
Elevance Health Inc (ELV) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid Strategic Repositioning
04:02pm, Wednesday, 28'th Jan 2026
Adjusted Diluted Earnings Per Share (EPS): $3.33 for Q4 2025; $30.29 for the full year 2025.Operating Revenue: $49.3 billion for Q4 2025, a 10% increase from t
Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums
01:25pm, Wednesday, 28'th Jan 2026
ELV tops Q4 EPS estimates as premiums grow and Carelon revenues surge, even as medical membership slips and expenses climb.
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript
01:02pm, Wednesday, 28'th Jan 2026
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript
Elevance Health Q4 Earnings Review: No Sign Of An End To The Pain
11:03am, Wednesday, 28'th Jan 2026
Elevance Health, Inc. faces persistent margin and volume pressures, with Q4 operating revenue down 55% YoY and weak 2026 guidance. ELV's benefit expense ratio remains elevated at 90%, with medical inf
Elevance Health (ELV) Reports Q4 Earnings: What Key Metrics Have to Say
10:31am, Wednesday, 28'th Jan 2026
Although the revenue and EPS for Elevance Health (ELV) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wa
US Health Insurer Elevance Health Issues Soft Outlook, Lower Premium Forecast For 2026
10:06am, Wednesday, 28'th Jan 2026
Elevance Health Inc. (NYSE: ELV) shares fell after the health insurer reported mixed fourth-quarter 2025 earnings and bleak fiscal 2026 guidance. The stock has recovered most of its loss from the prem
Elevance Health (ELV) Beats Q4 Earnings Estimates
08:11am, Wednesday, 28'th Jan 2026
Elevance Health (ELV) came out with quarterly earnings of $3.33 per share, beating the Zacks Consensus Estimate of $3.1 per share. This compares to earnings of $3.84 per share a year ago.
Elevance Health Stock Dives Again. Why Earnings Are Adding to Medicare Pain.
07:42am, Wednesday, 28'th Jan 2026
Elevance Health stock was set to fall for second consecutive day Wednesday.
Elevance Health Reports $547 Million Profit Despite Rising Costs
07:05am, Wednesday, 28'th Jan 2026
Elevance Health Wednesday reported fourth quarter net income of $547 million as healthcare cost issues continued to drag earnings of the health insurance giant.
Elevance forecasts 2026 profit below estimates on elevated medical costs
06:12am, Wednesday, 28'th Jan 2026
Elevance Health forecast 2026 profit below Wall Street expectations on Wednesday, as the health insurer expects higher medical costs to persist into the year.
Elevance Health Reports Fourth Quarter and Full Year 2025 Results; Sets Full Year 2026 Outlook
06:00am, Wednesday, 28'th Jan 2026
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2025 results. "Elevance Health delivered fourth quarter results in line with our outlook, reflect
Cambiar Investors LLC Buys 18,730 Shares of Elevance Health, Inc. $ELV
05:58am, Wednesday, 28'th Jan 2026
Cambiar Investors LLC grew its stake in Elevance Health, Inc. (NYSE: ELV) by 12.6% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Com
